Long-term efficacy and safety of androgen receptor inhibitor ODM-201 in ARADES phase I/II trial.
暂无分享，去创建一个
T. Tammela | V. Kataja | H. Joensuu | N. James | Jorge A. Garcia | K. Fizazi | C. Massard | P. Bono | A. Protheroe | P. Langmuir | T. Elliot | A. Vuorela | M. Mustonen | J. Aspegrén | L. Mattila | Robert Jones